Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention-Ethics Subcommittee (ES), 30409-30410 [2010-13014]

Download as PDF Federal Register / Vol. 75, No. 104 / Tuesday, June 1, 2010 / Notices Biomedical Research and Research Training Review Subcommittee B. Date: June 18, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Arthur L. Zachary, PhD, Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, Natcher Building, Room 3AN–18, Bethesda, MD 20892, (301) 594–2886, zacharya@nigms.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives, National Institutes of Health, HHS) Dated: May 25, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Interest Projects (SIPs): Workplace Health Research Network (WHRN)— Coordinating Center, SIP 10–031 and WHRN—Collaborating Centers, SIP 10– 032, Initial Review erowe on DSK5CLS3C1PROD with NOTICES In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 11 a.m.–5 p.m., June 29, 2010 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Workplace Health Research Network (WHRN)—Coordinating Center, SIP 10–031 and WHRN—Collaborating Centers, SIP 10–032, initial review.’’ Contact Person for More Information: Michelle Mathieson, Public Health Analyst, National Center for Chronic Disease and Health Promotion, Office of the Director, 15:41 May 28, 2010 Jkt 220001 Dated: May 20, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. Dated: May 21, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Centers for Disease Control and Prevention [FR Doc. 2010–13101 Filed 6–01–10; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings [FR Doc. 2010–13040 Filed 5–28–10; 8:45 am] VerDate Mar<15>2010 Extramural Research Program Office, CDC, 4770 Buford Highway, NE., Mailstop K–92, Atlanta, GA 30341, Telephone: (770) 488– 3068, E-mail: mth8@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. 30409 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Neurological Disorders and Stroke Initial Review Group, Neurological Sciences and Disorders K. Date: June 21, 2010. Time: 8 a.m. to 6:30 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Shanta Rajaram, PhD, Scientific Review Officer, Scientific Review Branch, NINDS/NIH/DHHS, 6001 Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD 20852. 301–435–6033. Rajarams@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 [FR Doc. 2010–12780 Filed 5–28–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention—Ethics Subcommittee (ES) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned subcommittee: Time and Date: 1 p.m.–3:30 p.m., June 17, 2010. Place: Teleconference. To participate, please dial (866) 919–3560 and enter passcode 4168828 for access. Status: Open to the public, limited only by availability of telephone ports. The public is welcome to participate during the public comment periods. A public comment period is tentatively scheduled for 3 p.m.–3:15 p.m. Purpose: The ES will provide counsel to the ACD, CDC, regarding a broad range of public health ethics questions and issues arising from programs, scientists and practitioners. Matter to be Discussed: Agenda items will include the following topics: Development of a strategy to support state and local health departments in their efforts to address public health ethics issues and coordination of these efforts with the CDC Office of State, Tribal, Local, and Territorial Support; steps for addressing ACD input on the ventilator guidance document; development of public health ethics cases; future priorities for the ES; and updates on CDC’s public health ethics activities. The agenda is subject to change as priorities dictate. Contact Person for More Information: Drue Barrett, PhD, Designated Federal Officer, ACD, CDC–ES, 1600 Clifton Road, N.E., M/S D–50, Atlanta, GA 30333. Telephone: (404) 639–4690. Email: dbarrett@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. E:\FR\FM\01JNN1.SGM 01JNN1 30410 Federal Register / Vol. 75, No. 104 / Tuesday, June 1, 2010 / Notices Dated: May 21, 2010. Elaine L. Baker, Director, Management Analysis and Service Office, Centers for Disease Control and Prevention. [FR Doc. 2010–13014 Filed 5–28–10; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Interest Project (SIP): Provider and Public Health Input for Vaccine Policy Decisions SIP 10–036, Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: erowe on DSK5CLS3C1PROD with NOTICES Time and Date: 11 a.m.–5 p.m., June 18, 2010 (Closed) Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Provider and Public Health Input for Vaccine Policy Decisions, SIP 10–036.’’ Contact Person for More Information: Michelle Mathieson, Public Health Analyst, National Center for Chronic Disease and Health Promotion, Office of the Director, Extramural Research Program Office, 4770 Buford Highway, NE., Mailstop K–92, Atlanta, GA 30341, Telephone: (770) 488– 3068, E-mail: mth8@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: May 21, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2010–13011 Filed 5–28–10; 8:45 am] BILLING CODE 4163–18–P VerDate Mar<15>2010 15:41 May 28, 2010 Jkt 220001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Interest Projects (SIPs): Outcomes of Screening American Indian/Alaska Native Women of Reproductive Age for Chronic Conditions in Reproductive Health Clinics & Technical Support for Health Systems Evaluations Within Africa and Asia under the President’s Emergency Plan for AIDS Relief (PEPFAR) SIP 10–034 and SIP 10–038, Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92– 463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 1 p.m.–4 p.m., June 25, 2010 (Closed) Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Outcomes of Screening American Indian/Alaska Native Women of Reproductive Age for Chronic Conditions in Reproductive Health Clinics & Technical Support for Health Systems Evaluations within Africa and Asia under PEPFAR, SIP 10–034 and SIP 10–038.’’ Contact Person for More Information: Michelle Mathieson, Public Health Analyst, National Center for Chronic Disease and Health Promotion, Office of the Director, Extramural Research Program Office, 4770 Buford Highway, NE., Mailstop K–92, Atlanta, GA 30341, Telephone: (770) 488–3068, E-mail: mth8@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. PO 00000 Frm 00047 Fmt 4703 Sfmt 9990 Dated: May 21, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2010–13104 Filed 5–28–10; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel, Dynamics of Host-Associated Microbial Communities (R01). Date: June 24, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, Bethesda, MD 20814. Contact Person: Arthur L. Zachary, PhD, Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, Natcher Building, Room 3AN–12, Bethesda, MD 20892. (301) 594–2886. zacharya@nigms.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives, National Institutes of Health, HHS) Dated: May 25, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–13042 Filed 5–28–10; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\01JNN1.SGM 01JNN1

Agencies

[Federal Register Volume 75, Number 104 (Tuesday, June 1, 2010)]
[Notices]
[Pages 30409-30410]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-13014]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee to the Director (ACD), Centers for Disease 
Control and Prevention--Ethics Subcommittee (ES)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
subcommittee:
    Time and Date: 1 p.m.-3:30 p.m., June 17, 2010.
    Place: Teleconference. To participate, please dial (866) 919-3560 
and enter passcode 4168828 for access.
    Status: Open to the public, limited only by availability of 
telephone ports. The public is welcome to participate during the public 
comment periods. A public comment period is tentatively scheduled for 3 
p.m.-3:15 p.m.
    Purpose: The ES will provide counsel to the ACD, CDC, regarding a 
broad range of public health ethics questions and issues arising from 
programs, scientists and practitioners.
    Matter to be Discussed: Agenda items will include the following 
topics: Development of a strategy to support state and local health 
departments in their efforts to address public health ethics issues and 
coordination of these efforts with the CDC Office of State, Tribal, 
Local, and Territorial Support; steps for addressing ACD input on the 
ventilator guidance document; development of public health ethics 
cases; future priorities for the ES; and updates on CDC's public health 
ethics activities.
    The agenda is subject to change as priorities dictate.
    Contact Person for More Information: Drue Barrett, PhD, Designated 
Federal Officer, ACD, CDC-ES, 1600 Clifton Road, N.E., M/S D-50, 
Atlanta, GA 30333. Telephone: (404) 639-4690. E-mail: dbarrett@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.


[[Page 30410]]


    Dated: May 21, 2010.
Elaine L. Baker,
Director, Management Analysis and Service Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2010-13014 Filed 5-28-10; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.